Price $1.35 |
Market Cap
148.6M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
14.58
|
P/S
20.78
|
Dividend %
-
|
|
P/CF
6.3
|
P/FCF
-
|
Op. Cash Flow
-30.3K
|
FCF
-0.6
|
|
Op. Margin
-549.30%
|
Net Margin
-379.30%
|
ROE
276.20%
|
ROI
128.90%
|
|
ROA
-49.90%
|
EPS Growth
66.10%
|
Current Ratio
1.2
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| PetIQ Inc (PETQ) | $34.59 | - | - | 1.06B | Strong Buy |
| Teva Pharmaceutical Industries (TEVA) | $12.55 | - | - | 10.6B | Strong Buy |
| China Pharma Holdings, Inc. (CPHI) | $0.68 | - | - | 19.8M | Strong Buy |
| Harvard Bioscience, Inc. (HBIO) | $4.39 | - | - | 166.4M | Strong Buy |
| Harrow Health Inc (HROW) | $8.63 | - | - | 159.6M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
